SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
Lancet Oncol, 26 (12), e683-e693
DOI 10.1016/S1470-2045(25)00520-0, PubMed 41308689
Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool
Nat Commun, 16 (1), 10151
DOI 10.1038/s41467-025-65218-9, PubMed 41258298
Accelerating precision oncology by converging pragmatic trials and real-world evidence
Nat Rev Drug Discov, 24 (11), 809-810
DOI 10.1038/d41573-025-00047-5, PubMed 40082591
More selected publications